For a company tipped to provide the NHS’s new overarching data platform, it is appropriate that Palantir Technologies is named after an all-seeing orb.
Palantir, which draws its name from the powerful crystal balls deployed in JRR Tolkien’s The Lord of the Rings, is the favourite to win a £360m contract for the NHS’s Federated Data Platform (FDP). Covering everything from individual patients’ data to vaccination programmes, waiting lists and medical trials, the FDP will aggregate data from multiple sources and different formats on to a single platform.
According to a document sent to potential bidders for the five-year contract, it will “provide access to real-time data to enable decision-making to better coordinate care”. Speaking at London Tech Week last week, the health secretary, Sajid Javid, said: “This is the perfect moment to bring data together and reap the benefits.”
The ambitious scope of the platform has alarmed campaign groups, who fear for patient confidentiality, privacy and data security, but the identity of the frontrunner has also caused concern.
US-based Palantir was co-founded by Peter Thiel, one of Silicon Valley’s few high-profile Donald Trump supporters. The $15.6bn (£12.7bn) company has been criticised for its work with the US immigration agency, as well as its intelligence service and defence contracts. It already works closely with NHS England by providing software that processes data for a variety of purposes including take-up of Covid-19 vaccines and managing the post-pandemic bounce back in elective care (surgery or treatment booked in advance).
But the prospect of it setting up an overarching data platform for NHS England has alarmed Foxglove, a UK legal campaign group that focuses on
Read more on theguardian.com